Clinical, Bronchoscopic, and Imaging Findings of e-Cigarette, or Vaping, Product Use-Associated Lung Injury Among Patients Treated at an Academic Medical Center.

ABSTRACT:

Importance

e-Cigarette, or vaping, product use-associated lung injury (EVALI) has caused more than 2800 illnesses and 68 deaths in the United States. Better characterization of this novel illness is needed to inform diagnosis and management.

Objective

To describe the clinical features, bronchoscopic findings, imaging patterns, and outcomes of EVALI.

Design, setting, and participants

This case series of 31 adult patients diagnosed with EVALI between June 24 and December 10, 2019, took place at an academic medical center in Salt Lake City, Utah.

Exposures

e-Cigarette use, also known as vaping.

Main outcomes and measures

Symptoms, laboratory findings, bronchoscopic results, imaging patterns, and clinical outcomes.

Results

Data from 31 patients (media

SUBMITTER: Aberegg SK 

PROVIDER: S-EPMC7648253 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature